A Phase I Study of Acapatamab, a Half-life Extended, PSMA-Targeting Bispecific T-cell Engager for Metastatic Castration-Resistant Prostate Cancer
- Tanya Dorff
- , Lisa G. Horvath
- , Karen Autio
- , Alice Bernard-Tessier
- , Matthew B. Rettig
- , Jean-Pascal Machiels
- , Mehmet A. Bilen
- , Martijn P. Lolkema
- , Nabil Adra
- , Sylvie Rottey
- , Richard Greil (Co-Autor/-in)
- , Nobuaki Matsubara
- , Daniel S. W. Tan
- , Alvin Wong
- , Hiroji Uemura
- , Charlotte Lemech
- , Johannes Meran
- , Youfei Yu
- , Mukul Minocha
- , Mason Mccomb
- City of Hope
- Chris O'Brien Lifehouse
- Memorial Sloan Kettering Cancer Center
- UNICANCER
- US Department of Veterans Affairs
- Universite Catholique Louvain
- Erasmus University Medical Center Rotterdam
- Amgen
- Indiana University System
- Salzburg Canc Res Inst CCCIT
- National Cancer Centre Singapore (NCCS)
- National University of Singapore
- Yokohama City University
- University of New South Wales Sydney
Publikation: Beitrag in Fachzeitschrift › Originalarbeit › Begutachtung
59
Quellenangaben
(Web of Science)